Evidence map›Paper›PMID 42409608›Full record

ArticleJournal of neuroendocrinology2026

Mapping of oxytocin- and arginine vasopressin-expressing neurons with calbindin 1 or reelin in the male mouse brain.

Naranbat Nasanbuyan, Masahide Yoshida, Yuki Takayanagi, Keiichi Itoi, Tatsushi Onaka

Abstract read
In one paragraph

Article in Journal of neuroendocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Naranbat NasanbuyanDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Masahide YoshidaDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.ORCID https://orcid.org/0000-0003-1247-2294
Yuki TakayanagiDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.
Keiichi ItoiGraduate School of Medicine, Tohoku University, Sendai, Japan.
Tatsushi OnakaDivision of Brain and Neurophysiology, Department of Physiology, Jichi Medical University, Shimotsuke, Japan.ORCID https://orcid.org/0000-0001-5666-9035

Funding

Japan Science and Technology Agency JPMJFR2067Japan Society for the Promotion of Science 23K18437Japan Society for the Promotion of Science 24K02863Japan Society for the Promotion of Science 24K10014Japan Society for the Promotion of Science 24K10028Japan Society for the Promotion of Science 25K10168the Takeda Science Foundationthe Vehicle Racing Commemorative Foundation
6 · The paper itself

Abstract

Oxytocin (OXT)- and arginine vasopressin (AVP)-synthesizing neurons are traditionally classified into magnocellular and parvocellular types based on their projection targets. However, molecular markers that reliably distinguish these neuronal subtypes across hypothalamic regions remain undefined. Recent single-cell transcriptomic studies suggest that Calb1 and Reln are differentially expressed in magnocellular and parvocellular OXT-synthesizing neurons in the hypothalamic paraventricular nucleus (PVN). Whether this molecular distinction extends to OXT neurons beyond the PVN or to AVP neurons has remained unclear. Fluorogold (FG) was administered to adult male C57BL/6J mice via tail vein injection. Calbindin 1 and reelin expression in OXT- and AVP-synthesizing neurons in the bed nucleus of the stria terminalis (BNST), PVN, supraoptic nucleus (SON), and retrochiasmatic supraoptic nucleus (SOR) was examined by immunocytochemistry. FG-labeled neurons were distributed in the PVN, SON, and SOR. Most OXT-immunoreactive (ir) neurons in the anterior PVN, SON, and SOR were FG-positive, whereas many OXT-ir neurons in the posterior PVN were FG-negative. Most FG-positive OXT-ir neurons showed calbindin 1 immunoreactivity. Two-thirds of FG-negative OXT-ir neurons in the posterior PVN expressed reelin. Almost all Reln-positive OXT-ir neurons were FG-negative. Nearly all AVP-ir neurons were FG-positive, and more than half expressed calbindin 1, whereas reelin expression was not detected. In corticotropin-releasing hormone (CRH)-Venus knock-in mice, AVP-ir neurons and CRH-positive neurons were not colocalized within the PVN, and AVP-ir and CRH-positive fibers were localized to distinct layers of the median eminence. These findings indicate that AVP expression in parvocellular CRH neurons was below the detection threshold of the methods used in this study. Calbindin 1 serves as a marker for magnocellular OXT neurons, whereas reelin identifies a subset of parvocellular OXT neurons. Given that the detected AVP-ir neurons were predominantly magnocellular, calbindin 1 labels a subset of this magnocellular AVP population. This molecular distinction provides a framework for distinguishing OXT- and AVP-expressing neuronal populations and for examining their respective roles in endocrine and behavioral regulation.

Indexed as

Arginine VasopressinBrainCalbindin 1Cell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsNerve Tissue ProteinsNeuronsOxytocinSerine EndopeptidasesAnimalsMaleMiceMice, Inbred C57BLReelin ProteinArginine VasopressinCalbindin 1Cell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsNerve Tissue ProteinsOxytocinReelin ProteinReln protein, mouseSerine Endopeptidasesarginine vasopressinCalbindin 1Corticotropin‐releasing hormoneoxytocinReelin

Identifiers

PMID42409608
PMCPMC13337333

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.